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Essentials
• The best imaging modality for joint blood detection in hemophilia is unknown.
• Blood appearance and detection thresholds were studied with ultrasound and conventional MRI.
• Ultrasound is sensitive to low volume and concentration of blood, whereas conventional MRI is not.
• The findings establish the validity of ultrasound for rapid bleed detection in hemophilia care.
Summary. Background: There is increasing demand for musculoskeletal ultrasound (MSKUS) to detect hemophilic joint bleeding, but there is uncertainty regarding blood detection concentration thresholds or if magnetic resonance imaging (MRI) is more accurate. Aims: Compare the sensitivity of blood detection by MSKUS and MRI. Methods: Increasing blood concentrations in plasma were imaged with MSKUS and MRI 1-2 h, 3-4 days and 7 days after blood withdrawal in vitro, and after injection into cadaveric pig joints. Additionally, effusions in the joints of two patients with hemophilia joints were imaged, followed by aspiration. MSKUS was performed using an 8-18-MHz linear transducer; MRI was performed at 3T using T1-weighted and T2-weighted fat-suppressed sequences. Images were reviewed by a hematologist certified in MSKUS and a musculoskeletal radiologist. Results: MSKUS permitted the detection of blood in vitro and in pig joint spaces at concentrations as low as 5%, demonstrated by the presence of echogenic signals that were absent with plasma alone. In contrast, no differences between fluids were discernible on the T1-weighted or T2-weighted MRI images. Results were confirmed in the two patients with hemophilia. Blood clots demonstrated varying and dynamic echogenicity patterns over time and, using MRI, were visualized best with T2 sequences. Conclusion: MSKUS is extremely sensitive in detecting low concentrations of intra-articular blood and in discriminating between bloody and non-bloody fluid, whereas conventional MRI is not. These observa
Introduction
Hemophilia patients require lifelong clotting factor replacement therapy to mitigate spontaneous joint bleeding and other life-threatening bleeding. However, clotting factor replacement therapy is costly and imposes a high financial burden on individuals, healthcare systems and society in general [1] . Therefore, timely objective detection of acute or persistent joint bleeding in hemophilia patients has become increasingly important. [2] [3] [4] [5] .
Magnetic resonance imaging (MRI) is considered the 'reference standard' to detect various abnormalities in hemophilic arthropathy [6] . However, in the past few years, musculoskeletal ultrasound (MSKUS) has emerged as a point-of-care (POC) imaging tool to assess the extent of arthropathic changes [6] [7] [8] [9] , thus opening new avenues for the management of hemophilic arthropathy [2] [3] [4] [5] 10] and also rapid joint bleed detection [2] [3] [4] 10] . Recent advances in technology, accessibility and training have made POC MSKUS an attractive alternative to MRI [11] in instances where imaging is desired. MSKUS is faster, more economical, and without the need for sedation for claustrophobic subjects or children. In addition, MSKUS does not require intravenous contrast to distinguish synovial proliferation from fluid and can also be used to assess synovial vascularity [12] [13] [14] .
MSKUS appears very adept at detecting joint effusions based on the ability of dynamic maneuvers during scanning. For hemophilia, this feature appears particularly valuable for the detection and management of hemarthrosis, where precise diagnosis of presence or absence of (bloody) effusions can complement patient or physician perception, thereby optimizing targeted treatment options [2] [3] [4] 10] . It allows visualization of shifting fluid in communicating spaces as well as sonopalpation. Sonopalpation assesses compressibility and displacement of echogenic intra-articular material. Effusions can be separated into simple vs. complex. Complex fluid accumulations are characterized by mixed echogenicity and displaceable speckles, indicating the presence of particulate matter such as proteins or blood products, whereas simple effusions appear anechoic with clear and serous fluid upon aspiration [15] [16] [17] [18] . Thus, MSKUS not only documents the presence of an effusion, but also distinguishes between bloody vs. non-bloody effusions based on echogenicity (echogenic versus anechoic) and presence of displaceable echogenic reflectors. In the context of hemophilia, complex effusions with echogenic reflectors can be assumed to represent blood products based on previous documentation of the great accuracy of this approach as documented by joint aspiration [4, 9] . MSKUS algorithms to detect hemarthrosis are therefore well defined, and can be performed quickly as part of the daily clinic routine, thereby fulfilling POC criteria [19] . Moreover, MSKUS enables guided aspiration and fluid analysis as clinically indicated.
In this context, it is noteworthy that radiological MRI criteria to assess blood contents in the joint are less well defined, and mainly derived from previous neurological studies [20, 21] . A preliminary study 30 years ago suggested that MRI may not have the same usefulness for distinguishing between bloody and non-bloody effusions in joints [22] . However, formal studies employing modern imaging technology are lacking, and clinical imaging interpretation algorithms more commonly use inference rather than evidence. Moreover, in daily clinical practice, joint effusions on MRI automatically may be deemed as bloody if arising in the context of hemophilia.
The recent increasing demand for use of MSKUS to detect hemophilic joint bleeding in the clinic is paired with the necessity to improve diagnostic accuracy for many new and evolving strategies for the management of hemophilic arthropathy [23] . This provided the incentive to study the appearance of blood products and blood detection concentration thresholds with MSKUS in vitro and in a cadaver model, and determine applicability to human hemophilic joints. We compared MSKUS imaging results with conventional MRI, which is, despite absence of solid evidence, currently considered to be the 'reference standard' for blood detection.
Materials and methods

Blood collection and sample preparation
Whole blood (termed 'Blood') was withdrawn from healthy donors into a syringe without anticoagulant and diluted into normal saline (NS) or into normal pooled plasma (NP) enriched with 2 mg mL À1 high-molecularweight hyaluronic acid (Fisher Scientific Company, LLC, Pittsburgh, PA, USA). The following dilutions were prepared: 0%, 5%, 10%, 25%, 50%, 75% and 100% blood into a final volume of 3-5 mL. The diluted blood samples were either contained in 3-6-mL syringes or injected into the metatarsophalangeal (MTP) joints of cadaveric pig feet for imaging. Between imaging sessions, the syringes and cadaveric pig feet containing blood dilutions were stored for up to 1 week at %24°C and %4°C, respectively. Approximately five repetitions of most dilutions and time-points were performed for the in vitro portion of the study. For cadaveric pig feet imaging two metatarsal joints per foot (n % 25 feet; 50 joints) were injected to afford one to two repetitions of most dilutions and time-points.
Sample preparation prior to imaging
The syringes were carefully shaken to obtain homogeneous bloody fluid while not disrupting blood clots. The cadaveric pig feet were removed from the refrigerator and equilibrated to room temperature. For in vitro experiments, ultrasound imaging of blood dilutions was performed with the transducer aligned in parallel with the syringes in a vertical position (Fig. 1A) . To visualize fluid in the syringes, brightness adjustments required optimization beyond the manufacturer's recommendations based on imaging fluid in syringes rather than within tissue with gain settings up to 90%. Ultrasound examinations of the cadaveric pig MTP joints were performed in longitudinal and transverse axes. Sonopalpation was used to evaluate compressibility and displacement of the intra-articular material. Imaging was performed shortly after blood collection, at day 1, days 3-4 and day 7 at room temperature. In vitro and cadaveric ultrasound imaging was performed by a medicine resident (SN), trained in the continuing medical education-accredited course 'Musculoskeletal Ultrasound in Hemophilia' at the Hemophilia and Thrombosis Treatment Center at University of California, San Diego, with an additional 50 h of practice prior to the initiation of the experiments. All ultrasound studies were supervised by a hematologist (AvD, with 5 years of musculoskeletal US experience) who was formally trained and certified in MSKUS through the American Registry for Diagnostic Medical Sonography (ARDMS).
For patient imaging, gray-scale examinations were performed according to standardized imaging protocols for each joint area as previously described [7] . Transducer positions for the knee comprised five distinct views to visualize the suprapatellar recess, femoral trochlear cartilage (sunrise view), medial and lateral patellofemoral gutters, and medial femorotibial space. MSKUS presets as recommended by the manufacturer were used. Echogenicity of tissues was judged by conventional ultrasound criteria as predominantly anechoic, hypoechoic or hyperechoic in relation to echogenicity of fatty tissue [24] . Sonopalpation was used to evaluate compressibility and displacement of intra-articular material. MSKUS-guided arthrocentesis was performed for effusions. Informed consent was obtained for each procedure. Human knee joint evaluations and aspirations were performed by the trained and certified hematologist (AvD).
MRI All MR imaging was performed on a 3T scanner (MR750, GE Healthcare, Milwaukee, WI, USA) using dedicated extremity coils. Similarly to MSKUS, experiments included the following time-points: shortly after blood collection, at day 1, days 3-4, and day 7 at room temperature.
Included in the field of view (FOV) of all images was a syringe containing pig muscle. The MRI protocol included fast spin-echo (FSE) T1-weighted (repetition time/echo time [TR/TE], 500-750 ms/7-9 ms) and T2-weighted fat-suppressed (TR/TE, 3064-7847 ms/68-70 ms) sequences. For patient imaging, conventional MRI protocols were employed, including axial FSE T1-weighted (TR/TE, 500 ms/9 ms), sagittal FSE T1-weighted (TR/TE, 758 ms/12 ms), and FSE T2-weighted fat-suppressed (TR/TE, 2650-5310 ms/66-77 ms) sequences.
Image analysis
On MSKUS, the echogenicity of fluid in the syringes, in MTP joints of cadaveric pig feet and in human joints was qualitatively recorded as anechoic or hypo-/hyperechoic. Compressibility of spaces upon sonopalpation in human joints and cadaveric pig MTP joints was diagnostic for the presence of fluid. The in vitro images of blood dilutions shortly after blood withdrawal were analyzed on an 8-bit gray scale with ImageJ software (National Institutes of Health, Bethesda, MD, USA) to quantify the number of pixels within gray areas corresponding to echogenicity. All images were set in identical windows and subjected to post-processing modifications to ensure congruency of brightness and contrast.
MR images were evaluated by a musculoskeletal radiologist (EYC). The signal intensity of fluid in the syringes, MTP joints of cadaveric pig feet and human joints was qualitatively recorded as iso-, hypo-or hyperintense relative to muscle.
With regard to comparing interpretations of MSKUS and MRI in human joints, the musculoskeletal radiologist (EYC) was blinded to the MSKUS results and independently recorded and interpreted the appearance of intraarticular joint fluid on MRI. Interpretations of in vitro and cadaveric pig feet images obtained with MSKUS were performed by consensus after randomization (EYC, AVD and SN) while blinded to individual results, whereas interpretation of the corresponding randomized MR images was performed by the musculoskeletal radiologist (EYC).
Results
Time-course of ultrasound appearance of blood dilutions and clotted blood in vitro First, we established that normal saline, NP, NP with hyaluronic acid, or joint fluid, when contained in syringes, appeared anechoic on ultrasound. The fluids were indistinguishable from each other. Non-dissolved particles of hyaluronic acid in NP and bubbles in aspirated joint fluid generated coarse hyperechoic speckles, which were artefactual and could be clearly distinguished from homogeneously speckled, hypoechoic blood ( Figure S1 ). A schematic of transducer probe orientation performed during US imaging is depicted in Fig. 1(A) .
To determine the concentration threshold of blood detection and the appearance of aging blood products and clot formation over time in vitro, NP was diluted with increasing concentrations of freshly drawn human blood. The samples were imaged immediately, as well as over the time-course of 1 week. To mimic the composition of synovial fluid, the blood dilutions were enriched with high-molecular-weight hyaluronic acid at concentrations of 2 mg mL À1 . This concentration was chosen based on previous measurements yielding concentrations of 1-3 mg mL À1 hyaluronic acid in synovial fluids of normal volunteers and patients with arthritic conditions [25] . Hyaluronic acid is an abundant protein found in joint fluid and is thought to contribute to viscosity and joint lubrication [26] , as well as influencing fibrin clot formation in the joint space [27] . A mixture of NP and hyaluronic acid was used in lieu of joint fluid because the procurement of large amounts of normal joint fluid is practically difficult and NP is a major constituent of hemarthrosis. Furthermore, the identical anechoic appearance of joint fluid and NP on ultrasound provided assurance of relevant and interpretable results ( Figure S1 ). Ultrasound imaging of increasing dilutions of blood in NS or in NP with hyaluronic acid demonstrated that NS or NP with hyaluronic acid were anechoic. In contrast, with blood dilutions, a concentration as low as 5% generated echogenic signals ( Fig. 1; Figure S2 ). Visual inspection did not permit blood quantification based on echo intensity, although lower concentrations of blood (5 or 10%) appeared less echogenic than higher concentrations of blood (25-100%). When the appearance of blood serially diluted into NS was quantified by objective grey tone analysis it appeared that the percentage of grey signals increased proportionally with increasing concentrations of blood ( Figure S2B ). Altogether, these findings indicated that ultrasound could easily distinguish between bloody and non-bloody fluid in vitro, and that blood detection was feasible at very low blood concentrations. However, blood concentrations were not linearly associated with the magnitude of generated echogenicity.
Blood clot formation could be observed in non-diluted blood, as well as in partially diluted blood (down to 25-75%). Blood clot appearance in saline differed from plasma. Blood clots formed in plasma appeared hypoechoic with a line demarcating the separation from hypoechoic serosanguinous plasma (Fig. 1B) . In saline, blood clots appeared more hyperechoic when compared with the surrounding serosanginous fluid ( Figure S2A ).
Time-course of MRI appearance of blood dilutions and clotted blood in vitro
Increasing dilutions of blood in normal plasma enriched with 2 mg mL À1 hyaluronic acid were prepared for MRI, analogous to previous ultrasound imaging. Standard T1-weighted and T2-weighted fat-suppressed sequences were employed. In contrast to ultrasound imaging, conventional MRI could not qualitatively discriminate between the presence or absence of blood, nor distinguish between different blood concentrations. Increasing blood concentrations did not change signal intensity qualitatively in T1-weighted and T2-weighted FS images (Fig. 2) . However, blood clots were clearly visible on the T2-weighted FS sequences as hypointense signal areas relative to their surrounding serosanguinous fluid (Fig. 2B) . On the T1-weighted images, albeit much less clearly demarcated, faintly hyperintense signal areas were observed in 50-100% blood solutions at the 3-7-day time-point ( Fig. 2A) .
Time-course of ultrasound appearance of blood dilutions and clotted blood in the MTP joints of cadaveric pig feet
To investigate the ultrasound appearance of increasing blood dilutions against the background of musculoskeletal structures, blood diluted in NS or in NP was injected into cadaveric pig MTP joints for imaging at different time-points ( Fig. 3 and Figure S3 ). Hyaluronic acid was omitted in experiments employing tissue imaging to avoid confusion in terms of delineating soft tissue from fluid speckle artefacts generated by non-dissolving hyaluronic crystals as observed earlier in the in vitro experiments ( Figure S1 , Fig. 1 ). Real-time sonopalpation was performed during scanning sessions to help distinguish between fully compressible fluid vs partially to non-compressible soft tissues or clots. Similar to the in vitro experiment, NS and NP appeared anechoic after injection into the MTP joint space and did not change appearance over time. Fresh blood could be detected by a hypoechoic speckled appearance in concentrations as low as 5-10% (Fig. 3 and Figure S3 ). However, increasing concentrations of blood were not easily discernable by increasing echogenicity. As time proceeded to days 3-4 and onward, internal echoes were visible even at blood concentrations as low as 2.5-5% ( Figure S3 ). This observation potentially could be explained by sedimentation and concentration of blood cells at the bottom of the joint space, abutting neighboring soft tissues.
Blood clot formation was observed at higher concentrations of blood (≥ 50% in our dilution series), and the clots' appearance was hypoechoic in relation to surrounding soft tissue. Clot formation was distinguishable from fluid based on the lack of full compressibility (only partially compressible) with real-time sonopalpation and their stationary properties, in contrast to fully compressible and displaceable fluids (Fig. 3 and Figure S3 ). Increasing blood concentrations did not change signal intensity qualitatively in T1-and T2-weighted fat-suppressed images. Blood clots were most easily distinguishable on the T2-weighted fat-suppressed images because they were hypointense relative to surrounding serosanguinous fluid, but were also faintly observable as hyperechoic on the T1-weighted images after day 3. NP, normal pooled plasma; MRI, magnetic resonance imaging.
fat-suppressed images. Figure 4 depicts the appearance on MRI of MTP joints injected with either NP or 100% blood. Both injectables appeared to be isointense and hyperintense on the T1-weighted and T2-weighted FS sequences, respectively, and did not change appearance during the 1-week time-course. . Time-course of MRI appearance of blood dilutions and clotted blood in the MTP joints of cadaveric pig feet. NP, diluted with increasing concentrations of freshly drawn human blood (3-5 mL), was injected into the MTP joint space. Serial MRI was performed using T1-weighted and T2-weighted fat-suppressed sequences at the indicated time-points. Arrows: fluid-filled areas in the joint space. There was no appreciable difference in signal intensity between plasma and blood solutions on T1-and T2-weighted fat-suppressed sequences. NP, normal pooled plasma; MRI, magnetic resonance imaging; MTP, metatarsophalangeal.
Timely correlated MSKUS and MR images in two hemophilic patients with simple and bloody effusions
To demonstrate that the ultrasonographic and MRI appearance of non-bloody and bloody fluid obtained by in vitro and cadaveric imaging would apply to in vivo imaging, effusions were evaluated by timely correlated MSKUS and MRI in patients with hemophilia. Among 30 patients who obtained MSKUS and conventional MR imaging studies for the assessment of hemophilic arthropathy, two patients who presented with joint pain were studied within several hours followed by joint aspiration. Their results, presented in Fig. 5 , demonstrate that conventional MRI was unable to discern bloody from non-bloody fluid, whereas MSKUS could do so based on differences in echogenicity of compressible spaces. The first patient was a 70-year-old male with moderate hemophilia A, who presented with several weeks of fluctuating joint pains and swelling in a knee that had undergone arthroscopic meniscal repair several years previously. The second patient was a 57-year-old male with moderate hemophilia A, who presented with persistent knee pain and swelling 1 week after a fall.
On MSKUS, imaging through the suprapatellar recesses in the long axis and the lateral recesses in the short axis, employing real-time sonopalpation, revealed compressible spaces with anechoic signals for the first patient (Fig. 5A and B) , and granular and speckled signals with mixed echogenicity for the second patient ( Fig. 5E and F) . These observations were consistent with the ultrasonographic appearance of simple vs. complex effusions, indicating either serous or bloody contents, as confirmed by aspiration in both patients. In contrast, corresponding images of the same joint locations on MRI showed no differences in signal intensities between the patients. Sagittal T2-weighted FS and axial/sagittal T1-weighted sequences depicted the effusions as equally hyperintense and hypointense, respectively (Fig. 5C/D and Fig. 5G/H) . The qualitative signal intensity on MRI was the same, irrespective of fluid content and/or characteristics. Altogether, these findings align with the in vitro observations and cadaveric imaging, demonstrating that conventional MRI cannot easily distinguish bloody from non-bloody effusions. The MRI observations reported here may not pertain to the appearance of (partially) clotted blood or blood sediments in the joint, which, to our knowledge, have not yet been formally studied in vivo.
Discussion
Rapid and accurate detection of acute or persistent bleeding in the joints of patients with hemophilia has evolved as a critical shortcoming during the past several years and resulted in the development of POC MSKUS for improved and rapid diagnosis of bleeds [2] [3] [4] .
Findings from our study demonstrate that MRI cannot easily distinguish between bloody and non-bloody joint effusions, whereas MSKUS can. This has important clinical implications for hemophilia care because the prevailing opinion assumes that MRI is the 'reference standard' for blood detection in the joints, despite a lack of supporting evidence. In contrast, MSKUS was highly sensitive for detecting blood at rather low concentrations (5-10% blood) in low volumes (3-5 mL) . This is noteworthy when considering that normal joint fluid volumes are described to be only a few milliliters in larger joints [28, 29] . Although our results stem from a series of in vitro and cadaveric pig studies, the relevance to human pathology was provided by simultaneous imaging of hemophilic joints with conventional MRI and MSKUS, followed by definitive proof through joint aspiration.
Bloody fluid appeared homogenously echogenic on ultrasound, and compressible with displaceable echogenic reflectors upon sonopalpation. Bloody fluid could be easily distinguished from anechoic serous fluid in vitro, in cadaveric pig joints and in live human joints. Echogenic properties of diluted blood remained relatively unchanged during the time-course of observation, although blood components presumably decayed to some extent. These observations highlight that red cells and blood components have no unique features on ultrasound, and may resemble other particulate or proteinaceous aggregates. Clinical scenarios such as joint infections may have similar ultrasound appearances. Also, it may be difficult to distinguish fresh bloody effusions (intact erythrocytes) from aging, serosanginous effusions (erythrocyte remnants). Therefore, additional evaluations such as aspiration with joint fluid analysis are warranted in the appropriate clinical context.
Blood clots tended to form once blood concentration was increased to 50-75%. The clots were most visible on T2-weighted FS sequences on MRI, with easier discrimination from surrounding fluid and soft tissue compared with ultrasound. Especially in vitro, this observation is consistent with previous studies [30, 31] . On MSKUS, blood clots appeared partially compressible, hypoechoic, variable in appearance, with little structural detail. Previous ultrasound studies imaging clot formation in vitro, or investigating composition of explanted blood clots, noted that echogenicity of clots can vary based on parameters such as red cell and/or platelet contents, extent of clot retraction or compression, and fibrin mesh composition [31] [32] [33] .
This study has several limitations. First, the cadaveric imaging studies were performed in relatively small joints. Although the size of a joint should not affect blood concentration detection, we acknowledge that larger joints have more capacity to accumulate larger effusions, which may alter imaging physics slightly. In clinical practice, the need for higher tissue penetration with larger effusions or more surrounding soft tissue is addressed by adjustments of penetration depth, gray scale (B-mode settings), transducer frequency and positioning, in part as per manufacturers' presets for different joints. Therefore, the type or size of joints may influence the threshold of blood concentration recognition in relation to volume on ultrasound slightly, but the trend and overall conclusions should remain the same. Second, the formation of blood clots in our study was artificial, lacking correct proportions and/or continued supply of blood and joint fluid constituents that regulate clot formation and fibrinolysis. The described appearance may be contrived and not apply in vivo. Echogenicity changes of aging blood products over time, especially in hemophilic joints, will require targeted investigations to develop appropriate diagnostic algorithms for POC MSKUS evaluation of intra-articular blood clot formation and resolution. Third, although MRI criteria for fluid assessment are well defined, this study relies on MRI readings provided by one, although very experienced, musculoskeletal radiologist. Fourth, although our observations provided proof-of-principle regarding the applicability of ultrasound appearances of serous and bloody joint effusions, continued validation in prospective studies is necessary.
Our study has several important clinical implications. Although MRI has excellent sensitivity for the detection of acute intracranial hemorrhage and vascular diseases [34] [35] [36] , our findings do not support that conventional MRI can reliably discriminate the complexity of intraarticular fluid in the absence of blood clots or aging blood products. Our findings regarding a potential limitation in detecting intra-articular blood are corroborated by the pilot study from Beltran et al., which described the similarity of signal intensities in MRI sequences of intraarticular injection of normal saline and fresh blood into healthy immature swine knees [22] .
In contrast, MSKUS appears very sensitive and appropriate for rapid bleed detection in hemophilic joints. Aspiration of an effusion may be required to determine red cell content or hematocrit if clinically important because blood concentration quantification based on differences in echogenicity appeared difficult with current usual ultrasound settings. However, in current clinical practice, visual inspection appears sufficient to determine the presence or absence of blood in the POC setting.
In conclusion, MSKUS is extremely sensitive for detecting low concentrations of intra-articular blood at low volumes, and discriminating between bloody and non-bloody fluid, whereas conventional MRI is not. These observations demonstrate the advantages of MSKUS over MRI in detecting intra-articular blood, and establish POC MSKUS for rapid bleed detection as a major advancement for the management of hemophilic arthropathy. 
